Tumorigenicity-associated characteristics of human iPS cell lines

Author:

Yasuda SatoshiORCID,Kusakawa Shinji,Kuroda Takuya,Miura Takumi,Tano Keiko,Takada Nozomi,Matsuyama Satoko,Matsuyama Akifumi,Nasu Michiyo,Umezawa Akihiro,Hayakawa Takao,Tsutsumi Hideki,Sato YojiORCID

Funder

Japanese Ministry of Health, Labour and Welfare

Japan Agency for Medical Research and Development

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. Stem Cell Therapies in Clinical Trials: Progress and Challenges;A Trounson;Cell stem cell,2015

2. Lessons from human teratomas to guide development of safe stem cell therapies;JJ Cunningham;Nature biotechnology,2012

3. WHO Expert Committee on Biological Standardization: Sixty-first Report. WHO Technical Report Series, No. 978 Annex 3. Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks: World Health Organization; 2013. 79–187 p.

4. Characterization of in vivo tumorigenicity tests using severe immunodeficient NOD/Shi-scid IL2Rgnull mice for detection of tumorigenic cellular impurities in human cell-processed therapeutic products;S Kusakawa;Regen Ther,2015

5. A ROCK inhibitor permits survival of dissociated human embryonic stem cells;K Watanabe;Nature biotechnology,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3